{"url_path":"/sec/cnxu/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/2066836/0001062993-26-003207-index.html","accession_number":"0001062993-26-003207","cik":"0002066836","ticker":"CNXU","issuer_name":"Conexeu Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2066836/0001062993-26-003207-index.html","primary_entity_key":"0002066836","primary_entity_name":"Conexeu Sciences Inc."},"word_count":378,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\nThe following exhibits are included with this Quarterly Report:\n\n**Exhibit No.**\n**Description of Exhibit**\n\n[10.1*+‡](exhibit10-1.htm)\n[Board Member Agreement between Conexeu Sciences Inc. and April Burke, dated June 15, 2026](exhibit10-1.htm)\n\n[10.2*+‡](exhibit10-2.htm)\n[Board Member Agreement between Conexeu Sciences Inc. and Ana Lucia Bastiani-Posner, dated June 15, 2026](exhibit10-2.htm)\n\n[10.3*+‡](exhibit10-3.htm)\n[Board Member Agreement between Conexeu Sciences Inc. and Andrew Costa, dated June 15, 2026](exhibit10-3.htm)\n\n[10.4*+](exhibit10-4.htm)\n[Board Compensation Notice to Dr. Z. Paul Lorenc, dated June 15, 2026](exhibit10-4.htm)\n\n[10.5*+](exhibit10-5.htm)\n[Board Compensation Notice to Jeff Sharpe, dated June 15, 2026](exhibit10-5.htm)\n\n[10.6*+](exhibit10-6.htm)\n[Board Compensation Notice to Sebastian Purcell, dated June 15, 2026](exhibit10-6.htm)\n\n[10.7*+](exhibit10-7.htm)\n[Board Compensation Notice to Dr. Aaron Farberg, dated June 15, 2026](exhibit10-7.htm)\n\n[10.8*+](exhibit10-8.htm)\n[Executive Employment Agreement between Conexeu Sciences Inc. and David Bogart, dated June 15, 2026](exhibit10-8.htm)\n\n[31.1*](exhibit31-1.htm)\n[Certification of Chief Executive Officer pursuant to the Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).](exhibit31-1.htm)\n\n[31.2*](exhibit31-2.htm)\n[Certification of Chief Financial Officer pursuant to the Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).](exhibit31-2.htm)\n\n[32.1**](exhibit32-1.htm)\n[Certifications pursuant to the Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit32-1.htm)\n\n101.INS*\nInline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document\n\n[101.SCH*](cnxu-20260430.xsd)\n[Inline XBRL Taxonomy Extension Schema Document](cnxu-20260430.xsd)\n\n[101.CAL*](cnxu-20260430_cal.xml)\n[Inline XBRL Taxonomy Extension Calculation Linkbase Document](cnxu-20260430_cal.xml)\n\n[101.DEF*](cnxu-20260430_def.xml)\n[Inline XBRL Taxonomy Extension Definition Linkbase Document](cnxu-20260430_def.xml)\n\n[101.LAB*](cnxu-20260430_lab.xml)\n[Inline XBRL Taxonomy Extension Label Linkbase Document](cnxu-20260430_lab.xml)\n\n[101.PRE*](cnxu-20260430_pre.xml)\n[Inline XBRL Taxonomy Extension Presentation Linkbase Document](cnxu-20260430_pre.xml)\n\n104*\nCover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101 attachments)\n\nNotes:\n\n* Filed herewith.\n\n** Furnished herewith\n\n+ Indicates a management contract or compensatory plan\n\n‡ Portions of this exhibit have been omitted.\n\n42\n\n**SIGNATURES**\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n**CONEXEU SCIENCES INC.**\n\n \n \n \n\nDate: June 15, 2026\nBy:\n*/s/ Miles Harrison*\n\n \nName:\nMiles Harrison\n\n \nTitle:\nChief Executive Officer\n\n \n \n(Principal Executive Officer) and\nDirector\n\n \n \n \n\n \n \n \n\nDate: June 15, 2026\nBy:\n*/s/ Stephen D. Inouye*\n\n \nName:\nStephen D. Inouye\n\n \nTitle:\nChief Financial Officer\n\n \n \n(Principal Financial Officer and\nPrincipal Accounting Officer) and\nSecretary and Treasurer\n\n \n\n43"}